Posted by Michael Wonder on 02 Apr 2017
The nominee to run America’s drug regulator is a sound choice
1 April 2017 - Scott Gottlieb is close to the pharma industry but knows its tactics.
When the names of potential candidates for the new head of America’s regulatory agency for drugs, the FDA, were first circulated, you could almost hear the sound of jaws hitting desks throughout the pharmaceuticals industry. One contender was Jim O’Neill, head of Mithril Capital Management, an investment firm, who is such a libertarian that he doesn’t think the FDA should insist that medicines have to work. Another was Balaji Srinivasan, an entrepreneur from Silicon Valley, who thought roughly the same.
